OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Colchicine in Stable Coronary Artery Disease
Aernoud T.L. Fiolet, Stefan M. Nidorf, Arend Mosterd, et al.
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 30-40
Open Access | Times Cited: 26
Aernoud T.L. Fiolet, Stefan M. Nidorf, Arend Mosterd, et al.
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 30-40
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
Romy Hansildaar, Daisy Vedder, Milad Baniaamam, et al.
The Lancet Rheumatology (2020) Vol. 3, Iss. 1, pp. e58-e70
Open Access | Times Cited: 184
Romy Hansildaar, Daisy Vedder, Milad Baniaamam, et al.
The Lancet Rheumatology (2020) Vol. 3, Iss. 1, pp. e58-e70
Open Access | Times Cited: 184
Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease
Tjerk S.J. Opstal, Renate M. Hoogeveen, Aernoud T.L. Fiolet, et al.
Circulation (2020) Vol. 142, Iss. 20, pp. 1996-1998
Open Access | Times Cited: 116
Tjerk S.J. Opstal, Renate M. Hoogeveen, Aernoud T.L. Fiolet, et al.
Circulation (2020) Vol. 142, Iss. 20, pp. 1996-1998
Open Access | Times Cited: 116
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics
Stefan M. Nidorf, Aernoud T.L. Fiolet, John W. Eikelboom, et al.
American Heart Journal (2019) Vol. 218, pp. 46-56
Closed Access | Times Cited: 95
Stefan M. Nidorf, Aernoud T.L. Fiolet, John W. Eikelboom, et al.
American Heart Journal (2019) Vol. 218, pp. 46-56
Closed Access | Times Cited: 95
Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview
Stefan M. Nidorf, Peter L. Thompson
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 41-48
Closed Access | Times Cited: 71
Stefan M. Nidorf, Peter L. Thompson
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 41-48
Closed Access | Times Cited: 71
Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease
Meng Xia, Xueying Yang, Cheng Qian
The American Journal of Cardiology (2020) Vol. 140, pp. 33-38
Closed Access | Times Cited: 56
Meng Xia, Xueying Yang, Cheng Qian
The American Journal of Cardiology (2020) Vol. 140, pp. 33-38
Closed Access | Times Cited: 56
Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein
Aernoud T.L. Fiolet, Max J. M. Silvis, Tjerk S.J. Opstal, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237665-e0237665
Open Access | Times Cited: 43
Aernoud T.L. Fiolet, Max J. M. Silvis, Tjerk S.J. Opstal, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237665-e0237665
Open Access | Times Cited: 43
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome
Tjerk S.J. Opstal, Aernoud T.L. Fiolet, Amber van Broekhoven, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 9, pp. 859-866
Closed Access | Times Cited: 40
Tjerk S.J. Opstal, Aernoud T.L. Fiolet, Amber van Broekhoven, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 9, pp. 859-866
Closed Access | Times Cited: 40
New evidence on the role of inflammation in CVD risk
Alberto J. Lorenzatti, Maria Luz Servato
Current Opinion in Cardiology (2019) Vol. 34, Iss. 4, pp. 418-423
Closed Access | Times Cited: 34
Alberto J. Lorenzatti, Maria Luz Servato
Current Opinion in Cardiology (2019) Vol. 34, Iss. 4, pp. 418-423
Closed Access | Times Cited: 34
Infections as Novel Risk Factors of Atherosclerotic Cardiovascular Diseases: Pathophysiological Links and Therapeutic Implications
Piotr Szwed, Aleksandra Gąsecka, Mateusz Zawadka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2539-2539
Open Access | Times Cited: 24
Piotr Szwed, Aleksandra Gąsecka, Mateusz Zawadka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 12, pp. 2539-2539
Open Access | Times Cited: 24
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes
Leo F. Buckley, Peter Libby
Journal of Cardiovascular Pharmacology (2019) Vol. 74, Iss. 4, pp. 297-305
Closed Access | Times Cited: 27
Leo F. Buckley, Peter Libby
Journal of Cardiovascular Pharmacology (2019) Vol. 74, Iss. 4, pp. 297-305
Closed Access | Times Cited: 27
Risk of Major Adverse Cardiovascular Event Following Incident Hospitalization for Acute Gout: A Western Australian Population‐Level Linked Data Study
Derrick Lopez, Girish Dwivedi, Johannes C. Nossent, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 6, pp. 298-304
Open Access | Times Cited: 9
Derrick Lopez, Girish Dwivedi, Johannes C. Nossent, et al.
ACR Open Rheumatology (2023) Vol. 5, Iss. 6, pp. 298-304
Open Access | Times Cited: 9
Pathophysiology of atherosclerosis: Association of risk factors and treatment strategies using plant‐based bioactive compounds
Hina Sharif, Muhammad Sajid Hamid Akash, Kanwal Rehman, et al.
Journal of Food Biochemistry (2020) Vol. 44, Iss. 11
Open Access | Times Cited: 22
Hina Sharif, Muhammad Sajid Hamid Akash, Kanwal Rehman, et al.
Journal of Food Biochemistry (2020) Vol. 44, Iss. 11
Open Access | Times Cited: 22
Colchicine in Cardiovascular Disease: Repurposing an Ancient Gout Drug
Peter L. Thompson
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 8-10
Open Access | Times Cited: 19
Peter L. Thompson
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 8-10
Open Access | Times Cited: 19
Psoriasis and Cardiovascular Disease: A Narrative Review
A. Martínez‐Moreno, Jorge Ocampo‐Candiani, Verónica Garza‐Rodríguez
Korean Journal of Family Medicine (2020) Vol. 42, Iss. 5, pp. 345-355
Open Access | Times Cited: 16
A. Martínez‐Moreno, Jorge Ocampo‐Candiani, Verónica Garza‐Rodríguez
Korean Journal of Family Medicine (2020) Vol. 42, Iss. 5, pp. 345-355
Open Access | Times Cited: 16
Therapeutic Implications of NLRP3-Mediated Inflammation in Coronary Artery Disease
Gregory Hemenway, William H. Frishman
Cardiology in Review (2021) Vol. 30, Iss. 2, pp. 90-99
Closed Access | Times Cited: 14
Gregory Hemenway, William H. Frishman
Cardiology in Review (2021) Vol. 30, Iss. 2, pp. 90-99
Closed Access | Times Cited: 14
PROSPECTS FOR USING COLCHICINE IN MEDICINE: NEW EVIDENCE
Z S Alekberova, Е. Л. Насонов
Rheumatology Science and Practice (2020) Vol. 58, Iss. 2, pp. 183-190
Open Access | Times Cited: 14
Z S Alekberova, Е. Л. Насонов
Rheumatology Science and Practice (2020) Vol. 58, Iss. 2, pp. 183-190
Open Access | Times Cited: 14
Inflammation May be the Future of Cardiovascular Risk Reduction: Does Colchicine have a Current Indication?
Thomas F. Whayne
American Journal of Cardiovascular Drugs (2020) Vol. 21, Iss. 1, pp. 1-10
Closed Access | Times Cited: 11
Thomas F. Whayne
American Journal of Cardiovascular Drugs (2020) Vol. 21, Iss. 1, pp. 1-10
Closed Access | Times Cited: 11
Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis
Zujin Xiang, Jian Yang, Jun Yang, et al.
Internal and Emergency Medicine (2021) Vol. 16, Iss. 2, pp. 487-496
Closed Access | Times Cited: 10
Zujin Xiang, Jian Yang, Jun Yang, et al.
Internal and Emergency Medicine (2021) Vol. 16, Iss. 2, pp. 487-496
Closed Access | Times Cited: 10
Repurposing Drugs to Treat Heart and Brain Illness
Maranda S. Cantrell, Alejandro Soto-Avellaneda, Jackson D. Wall, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 573-573
Open Access | Times Cited: 5
Maranda S. Cantrell, Alejandro Soto-Avellaneda, Jackson D. Wall, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 573-573
Open Access | Times Cited: 5
Myocardial infarction in relation to colchicine poisoning: A precipitating cause of refractory toxic cardiogenic shock
Francis Grossenbacher, Guillaume Giordano Orsini, Yoann Cazaubon, et al.
Therapies (2020) Vol. 76, Iss. 1, pp. 51-53
Closed Access | Times Cited: 3
Francis Grossenbacher, Guillaume Giordano Orsini, Yoann Cazaubon, et al.
Therapies (2020) Vol. 76, Iss. 1, pp. 51-53
Closed Access | Times Cited: 3
Polypharmacology in Old Drug Rediscovery: Drug Repurposing
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 535-592
Closed Access | Times Cited: 2
Zhiguo Wang, Baofeng Yang
Springer eBooks (2022), pp. 535-592
Closed Access | Times Cited: 2
“Inflamma” and Other “Somes”
Richard I. Shader
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 2-5
Open Access
Richard I. Shader
Clinical Therapeutics (2018) Vol. 41, Iss. 1, pp. 2-5
Open Access
Image quality and diagnostic accuracy of different dosages of iodixanol in computed tomography angiography and perfusion of overweight patients with coronary artery stenosis: A feasibility study
Xiaoqiang Tang, Yong Zhang, Tao Wang, et al.
Medical Engineering & Physics (2022) Vol. 110, pp. 103818-103818
Closed Access
Xiaoqiang Tang, Yong Zhang, Tao Wang, et al.
Medical Engineering & Physics (2022) Vol. 110, pp. 103818-103818
Closed Access
CORONARY ARTERY DISEASE INFLAMMATORY PATHWAYS AND INTERVENTIONS
Maxim Jean Marie Silvis
(2022)
Open Access
Maxim Jean Marie Silvis
(2022)
Open Access
Autophagy Regulation by Lipid Factors with Implications for Parkinson's Disease
Alejandro Soto-Avellaneda
(2021)
Open Access
Alejandro Soto-Avellaneda
(2021)
Open Access
